A Study of AMNN107 in the Treatment of Metastatic and/or Inoperable Melanoma Harboring a c-Kit Mutation
Public ClinicalTrials.gov record NCT01028222. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
The TEAM Trial (Tasigna Efficacy in Advanced Melanoma): A Phase II, Open Label, Multi-center, Single-arm Study to Assess the Efficacy of Tasigna ® in the Treatment of Patients With Metastatic and/or Inoperable Melanoma Harboring a c-Kit Mutation
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine whether nilotinib is efficacious in the treatment of metastatic and/or inoperable melanoma harboring a c-Kit mutation.
Study identification
- NCT ID
- NCT01028222
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 55 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 2010 (Type not available)
- Primary completion
- Dec 2014 (Actual)
- Completion
- Dec 2014 (Actual)
- Last update posted
- Dec 30, 2015
2010 – 2014
United States locations
- U.S. sites
- 14
- U.S. states
- 10
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| City of Hope National Medical Center City of Hope national Med Ctr | Duarte | California | 91010-3000 | — |
| University of California San Diego - Moores Cancer Center UCSD Moores Cancer Center | La Jolla | California | 92093-0658 | — |
| University of California at Los Angeles UCLA | Los Angeles | California | 90024 | — |
| California Pacific Medical Center California Pacific Med | San Francisco | California | 94120-7999 | — |
| University of Colorado Univ Colorado 2 | Aurora | Colorado | 80045 | — |
| Rush University Medical Center SC | Chicago | Illinois | 60612 | — |
| Oncology Specialists, SC Dept.of Oncology Specialists | Park Ridge | Illinois | 60068-0736 | — |
| Sidney Kimmel Comprehensive Cancer Center/Johns Hopkins Med. Medical Oncology | Baltimore | Maryland | 21231 | — |
| Dana Farber Cancer Institute DFCI - Brookline | Boston | Massachusetts | 02215 | — |
| Mayo Clinic - Rochester Mayo Clinic- Gonda | Rochester | Minnesota | 55905 | — |
| Washington University School of Medicine CAMN107B2301 | St Louis | Missouri | 63110 | — |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10021 | — |
| Case Western Reserve Case Western | Cleveland | Ohio | 44106-5000 | — |
| Baylor Health Care System/Sammons Cancer Center Baylor 2 | Dallas | Texas | 75246 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 35 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01028222, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 30, 2015 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01028222 live on ClinicalTrials.gov.